Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Carmen Areses"'
Autor:
Sara Agraso, Martin Lázaro, Xose Luis Firvida, Lucía Santomé, Natalia Fernández, Cristina Azpitarte, Luis Leon, Carme Garcia, Gerardo Hudobro, Ma Carmen Areses, Begoña Campos, Nazaret Quiroga, Jorge García, Joaquín Casal
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100646- (2022)
Background: In clinical studies, first-line afatinib demonstrated efficacy in Del19-EGFR NSCLC. Materials and Methods: This prospective, non-interventional study assessed efficacy and safety of first-line afatinib in patients with advanced/metastatic
Externí odkaz:
https://doaj.org/article/a81081bffa4c44238446504a5dd7fd6b
Autor:
David Arias Ron, Carmen M. Labandeira, María Carmen Areses Manrique, Paula Sampedro Domarco, Ihab Abdulkader, Jesús García-Mata, Christian Rolfo, Diego González-Rivas, Jose Luis Fírvida
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
In a patient who had been diagnosed of located squamous cell lung carcinoma, pneumonectomy, and adjuvant chemotherapy were performed. Brain recurrence and subsequent lung metastatic disease were uncontrolled by neurosurgery, holocranial radiotherapy,
Externí odkaz:
https://doaj.org/article/0227a4fb32734cf9aced213326d3f9b3
Autor:
Gonzalo Garcia-Gonzalez, Eduardo Rios-Herranz, Leyre Chasco-Eguilaz, Macarena Real-Dominguez, Maria Isabel Asensio-Cruz, Ignacio Garcia-Escobar, Jose Maria Sanchez-Diaz, Iria Gallego-Gallego, Samira Marin-Romero, Maria Carmen Borrego-Delgado, Alfonso Revuelta-Rodriguez, Aitor Ballaz-Quincoces, Maria Carmen Areses, Jorge Lima-Alvarez, Lucia Marin-Barrera, Andres J Muñoz-Martin, Carmen Beato, Maria Barca-Hernando, Maria Angeles Moreno-Santos, Sergio Lopez-Ruz, Purificacion Estevez-Garcia, J.B. López-Sáez, Estefania Oncala-Sibajas, Remedios Otero-Candelera, Teresa Elias-Hernandez, Carme Font, Victor Rivas-Jimenez, Luis Jara-Palomares
Publikováno v:
Cancers 2021, 13(11), 2517
Cancers
Volume 13
Issue 11
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Cancers, Vol 13, Iss 2517, p 2517 (2021)
Cancers
Volume 13
Issue 11
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
instname
Cancers, Vol 13, Iss 2517, p 2517 (2021)
Anemia is a common condition in cancer patients and is associated with a wide variety of symptoms that impair quality of life (QoL). However, exactly how anemia affects QoL in cancer patients is unclear because of the inconsistencies in its definitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9028abc2d3e31db6c5897e8910767769
http://hdl.handle.net/10498/25316
http://hdl.handle.net/10498/25316
Autor:
Aurora Rodríguez, Mª Carmen Areses Manrique, Felipe Couñago, Jose Luis Fírvida, Xabier Mielgo, Juan Zafra, Juan Carlos Trujillo Reyes, Rodolfo Chicas-Sett, Amalia Sotoca, Javier Ras Luna
Publikováno v:
World Journal of Clinical Oncology
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Immunotherapy has represented one of the main medical revolutions of recent decades, and is currently a consolidated treatment for different types of tumors at different stages and scenarios, and is present in a multitude of clinical trials. One of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea9d9df3a0deb7c45fc3a2d776f4469
https://hdl.handle.net/11268/11656
https://hdl.handle.net/11268/11656
Autor:
Teodoro Martín-Noguerol, José Muñoz-Iglesias, Laura Oleaga, Juan Antonio Vallejo Casas, Jordi Broncano, María Carmen Areses, Joan C. Vilanova, Antonio Luna, Sandra Baleato-González, Roberto García-Figueiras
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 40(7)
Immunotherapy is changing the treatment paradigm for cancer and has introduced new challenges in medical imaging. Because not all patients benefit from immunotherapy, pretreatment imaging should be performed to identify not only prognostic factors bu
Autor:
Rocio Vilchez Simo, Maria Carmen Areses Manrique, María Rosario García Campelo, Cristina Azpitarte Raposeiras, Jose Muñoz Iglesias, Joaquín Martínez, Urbano Anido Herranz, F.J. Afonso, Natalia Fernández Núñez, David Arias Ron, Begoña Campos Balea, Martin Lázaro Quintela, Juan Ruiz Bañobre, Jorge García González, Margarita Amenedo Gancedo, Lucía Santomé Couto, José Luis Fírvida Pérez, Joaquin Casal Rubio, Jesús García Mata, Guillermo Alonso-Jaudenes Curbera, Iria Carou Frieiro
Publikováno v:
Journal of geriatric oncology. 12(3)
Background Nivolumab is an anti PD1 immunotherapy drug approved for advanced Non-Small Cell Lung Cancer (NSCLC) patients who previously received at least one prior line of treatment. Older patients are often not represented in clinical trials and dru
Autor:
Juan Ruiz-Bañobre, José Luis Fírvida Pérez, N. Fernández-Núñez, L. Crama, Martín Lázaro-Quintela, Francisco J. Afonso-Afonso, Pedro Ruiz-Gracia, Jorge García-González, Diego Pérez Parente, Margarita Amenedo-Gancedo, María Del Carmen Areses-Manrique, Lucía Santomé-Couto, Luis León-Mateos, Begoña Campos-Balea, Joaquín Casal-Rubio
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2093, p 2093 (2020)
Journal of Clinical Medicine
Journal of Clinical Medicine
The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option for advanced non-small-cell lung cancer (NSCLC). The aim of this meta-analysis was to evalu
Autor:
Juan Ruiz-Bañobre, Sergio Vázquez, María Del Carmen Areses-Manrique, Lucía Santomé, Jorge García-González, Cristina Azpitarte-Raposeiras, Noemí de Dios-Álvarez, N. Fernández-Núñez, Rosario García-Campelo, Joaquín Mosquera-Martínez, Alexandra Cortegoso, Jose L. Fírvida-Pérez, Joaquín Casal-Rubio, Margarita Amenedo, Francisco J. Afonso-Afonso
Publikováno v:
Transl Lung Cancer Res
The lung immune prognostic index (LIPI) has been proposed as a new categorical blood-based biomarker to select advanced non-small cell lung cancer (NSCLC) patients for anti-programmed cell death-1 (PD-1) or programmed death ligand 1 (PD-L1) therapy.
Autor:
Wenxia Qian, Gaohua Feng, Yadong Lu, Xiaoling Lu, Yufang Feng, Chunping Ma, Junyi Ye, Carmen Areses Manrique
Publikováno v:
Journal of Thoracic Disease. 10:5904-5912
Background: The utilization of cancer-linked genetic alterations for categorizing patients against optimal treatment is becoming increasingly popular, especially in non-small cell lung cancer (NSCLC). However, disadvantages of the conventional techni
Autor:
Natalia Fernández Núñez, Martin Lázaro Quintela, Iria Carou Frieiro, Joaquin Mosquera Martinez, Margarita Amenedo Gancedo, Joaquin Casal Rubio, Jose Muñoz Iglesias, Alexandra Sabela Cortegoso mosquera, Rocio Vilchez Simo, Urbano Anido Herranz, Jesús García Mata, Lucía Santomé Couto, Begoña Campos Balea, Mª Carmen Areses Manrique, Jorge García González, Mª Rosario García Campelo, Guillermo Alonso-Jaudenes Curbera, José Luis Fírvida Pérez, Cristina Azpitarte Raposeiras, F.J. Afonso
Publikováno v:
Translational Lung Cancer Research. 7:404-415
Background Recently, immunotherapy has changed the standard of treatment in non-small cell lung cancer (NSCLC). Outside clinical trials, data of real life is lacking. This is an observational study that represents the real world experience with nivol